Dare Bioscience, Inc. (DARE) Financials
DARE Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 22.4 million | 22.9 million |
| March 31, 2026 | 27.8 million | 27.1 million |
| Dec. 31, 2025 | 32.5 million | 29.6 million |
| Sept. 30, 2025 | 30.7 million | 27.9 million |
DARE Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -6.9 million | 286602 |
| March 31, 2026 | -5.5 million | 455064 |
| Dec. 31, 2025 | 1.2 million | 357160 |
| Sept. 30, 2025 | -616840 | 403027 |
DARE Net Income
No data available :(
DARE Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 12.6 million | - | - |
| March 31, 2026 | 18.5 million | - | 1.6 million |
| Dec. 31, 2025 | 24.7 million | - | 2.7 million |
| Sept. 30, 2025 | 23.1 million | - | 2.9 million |
DARE Shares Outstanding
DARE Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 80586 | 241966 | 2.6 million | - |
| March 31, 2026 | 4 | 152455 | 2.2 million | - |
| Dec. 31, 2025 | 206644 | 622041 | 1.6 million | - |
| Sept. 30, 2025 | 174705 | 1.2 million | 2.3 million | 202000 |
DARE Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | 187546 | 319889 |
| March 31, 2026 | 152455 | 796968 |
| Dec. 31, 2025 | 1.0 million | 295799 |
| Sept. 30, 2025 | 2262 | 1.2 million |
DARE Revenue by Segment
Graph available only for paid members. Upgrade to see it.
DARE
Price: $0.73
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 12.6 million